Visolyr® Unveils Agentic Adaptive Intelligence™
Advancing Patient-Centered Care for Cardiometabolic Disease
MCLEAN, VA, UNITED STATES, August 26, 2025 /EINPresswire.com/ -- Visolyr®, a leader in clinical AI innovation, today announced the launch of Agentic Adaptive Intelligence™, an innovative capability designed to redefine how clinicians engage with patient information and take action on it. By integrating longitudinal EMR records, diagnostic results, unstructured documentation, external datasets, and social determinants of health, Visolyr delivers real-time, evidence-based recommendations to inform patient-specific care decisions within clinical workflows.
Visolyr clinical AI platform is purpose-built for cardiometabolic disease, designed to reveal actionable insights directly at the point of care. With Agentic Adaptive Intelligence™, Visolyr interprets each patient scenario, identifies the most relevant questions, and generates precise, context-aware recommendations that adapt continuously, helping clinicians make well-informed treatment decisions.
"Agentic Adaptive Intelligence™ represents a fundamental shift in AI-driven healthcare technology," said Michael Joseph, Founder and CEO of Visolyr. "Instead of constraining care delivery within deterministic logic, static business rules, and pre-built workflows, our platform enhances workflows with autonomous reasoning, intent-aware assistance, and contextual understanding. The result is a personalized, intuitive, and frictionless user experience. Our collaboration with HITLAB provides a pathway for clinical validation through rigorous research that is infused with real-world clinical insights."
Visolyr is partnering with HITLAB to guide MVP evaluation, product-market fit, and clinical validation. “Visolyr’s Agentic Adaptive Intelligence™ has the potential to redefine how healthcare systems think about AI integration,” said Dr. Stan Kachnowski, Chair of HITLAB. “By embedding context-aware, autonomous intelligence directly at the point of care, Visolyr aims to deploy AI technology in ways that build trust, enhance usability, and demonstrate measurable clinical value.”
To accelerate performance and adoption, Visolyr is leveraging NVIDIA® NIM™ microservices, healthcare-tailored AI foundation models, and industry-leading GPU infrastructure. NVIDIA NIM provides prebuilt, optimized AI inference microservices for reasoning, speech, vision, and genomics, deployable across cloud, edge, and on-premises environments with enterprise-grade security, low latency, and seamless scalability. The platform also utilizes domain-optimized foundation models such as Llama Nemotron for advanced reasoning and Palmyra-Med-70B, a specialized large-language model for healthcare that has demonstrated strong accuracy (average 85.9%) across medical benchmarks, outperforming leading medical LLMs, integrated within the NIM ecosystem. As member of NVIDIA Inception, Visolyr gains access to best-in-class AI resources and expertise that accelerate development and advance its clinical AI capabilities.
About Visolyr
Visolyr is reimagining healthcare to navigate moments that matter. Its clinical AI platform combines autonomous agents, adaptive intelligence, and evidence-based reasoning to deliver proactive, personalized, and effective care. By embedding dynamic insights directly into clinical workflows, Visolyr empowers health systems to reduce complications, lower costs, and improve outcomes.
About HITLAB
HITLAB (Healthcare Innovation and Technology Lab) is a global leader in health innovation research and strategy. Through validation, education, and acceleration programs, HITLAB helps bring transformative digital health technologies to market and into the hands of those who need them most.
Media Relations
Visolyr®
press@visolyr.io
Visit us on social media:
LinkedIn
Visolyr® Announces Collaboration with HITLAB
McLean, VA – May 27, 2025 – Visolyr® a digital health platform focused on AI-powered clinical solutions, has partnered with HITLAB, a leading health innovation research lab, to accelerate the development and validation of a breakthrough Generative AI platform designed to transform healthcare delivery.
Under a strategic services agreement, HITLAB will support Visolyr® in building and refining its Generative and Agentic AI platform for healthcare through rigorous validation research, publication, business model development, investor engagement, and strategic partnerships. The collaboration aims to bring to market a clinically validated solution that improves clinical documentation, enhances decision support, elevates patient engagement and education, and strengthens medication management.
Visolyr®’s AI platform is engineered to accelerate digital health transformation by integrating Generative AI, AI agents, and intelligent automation directly into clinical workflows. With a focus on women’s health and high-burden conditions such as cardiometabolic diabetes—particularly in patients with kidney disease and hypertension—Visolyr® delivers personalized, proactive, and coordinated care. The platform enables enterprise-wide AI deployments that enhance clinician efficiency and improve patient experiences at the point of care.
Through its participation in the NVIDIA Inception program, Visolyr® has deployed NVIDIA Inference Microservices (NIM) to deliver sub-second, context-aware AI responses. This has powered Visolyr®’s latest demo capabilities, which include hybrid AI workflows, Retrieval-Augmented Generation (RAG) automation, dynamic model selection and context-aware orchestration.
“HITLAB is committed to accelerating the adoption of impactful technologies that address unmet healthcare needs,” said Dr. Stan Kachnowski, Chair of HITLAB. “Our collaboration with Visolyr® reflects our shared vision of using cutting-edge AI to streamline clinical processes, improve outcomes, and reduce costs.”
Visolyr® Founder and CEO Michael Joseph added, “Our partnership with HITLAB is a critical milestone in our mission to bring context-aware AI to the point of care. Together, we are advancing a platform that not only empowers clinicians but also personalizes the care journey for patients.”
HITLAB, known for initiatives such as the HITLAB World Cup, Women’s Health Tech Initiative, and Breakthrough Alliance, will also help position Visolyr®’s innovation within the broader healthcare ecosystem through seminars, conferences, and thought leadership.
About Visolyr®
Visolyr® is a healthcare AI platform that enables enterprise-scale deployment of Generative AI and intelligent agents within clinical workflows. Focused on enhancing clinical decision-making and streamlining care for complex chronic conditions, Visolyr® is on a mission to improve health outcomes, provider productivity and operational efficiency through next-generation technology at the forefront of AI innovation.
About HITLAB
HITLAB (Healthcare Innovation and Technology Lab) is a global leader in health innovation research and strategy. Through validation, education, and acceleration programs, HITLAB helps bring transformative digital health technologies to market and into the hands of those who need them most.
Visolyr® Selected for NVIDIA® Inception
Visolyr® is pleased to announce our acceptance in NVIDIA Inception, a program that nurtures startups revolutionizing industries, including healthcare, with technological advancements to harness the power of AI and high-performance computing. NVIDIA’s healthcare solutions are designed to address critical challenges in the industry, from operational efficiency to clinical innovation, enabling better outcomes for patients and easing burden on providers. NVIDIA provides a range of AI-powered solutions and platforms tailored for the healthcare and life sciences industries, leveraging its GPU technologies and AI expertise.
Joining NVIDIA Inception will help Visolyr® achieve our strategic goals and product maturity through go-to-market support, training courses, technical workshops and tools, and industry events. We look forward to exploring and leveraging the vast resources in NVIDIA Deep Learning Institute and NVIDIA Developer Forums. NVIDIA Inception will also offer the Visolyr® team the opportunity to collaborate with industry-leading experts and other AI-driven organizations, infusing our platform's capabilities and features with best-in-class technology.
NVIDIA Inception supports Visolyr®'s mission to revolutionize healthcare by harnessing the power of data and artificial intelligence to create innovative solutions that improve patient engagement, empower healthcare providers and deliver exceptional user experience. NVIDIA Inception helps startups during critical stages of product development, prototyping and deployment. Every Inception member gets a custom set of ongoing benefits, such as NVIDIA Deep Learning Institute credits, preferred pricing on NVIDIA hardware and software, and technological assistance, which provides startups with the fundamental tools to help them grow.